<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Sorrento Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Sorrento Therapeutics, Inc.

    Sorrento’s lead programs with short-term milestones consist of two clinical stage immuno-oncology therapies (CD38 CAR-T and CEA CAR-T), and two pain franchise programs (license application review Phase for ZTlido NDA and RTX Phase Ib single epidural injection for cancer pain). Sorrento is also advancing a portfolio of adoptive cellular therapies, immuno-oncology mAbs, antibody drug conjugates (ADCs), intracellular targeting antibodies and an oncolytic viral vector (Seprevir®). Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      8731
    • NIN CODE
      ####
    • LEADERSHIP
      Dr. Henry Ji
    • FOUNDED
      2006
    • EMPLOYEES
      251-500
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Nabriva Therapeutics plc

    Nabriva Therapeutics plc

    Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in th...

    Nabriva Therapeutics is a commercial-stage biop...

    Filing Type:    PU

    Predictive Oncology Inc.

    Predictive Oncology is a clinical and translational data pipeline and AI-driven pl...

    Predictive Oncology is a clinical and translati...

    Filing Type:    PU
    Kura Oncology, Inc.

    Kura Oncology, Inc.

    We are a clinical-stage biopharmaceutical company committed to realizing the promi...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    CohBar, Inc.

    CohBar, Inc.

    CohBar, Inc. is a leader in the research and development of mitochondria based the...

    CohBar, Inc. is a leader in the research and de...

    Filing Type:    PU
    Translate Bio, Inc.

    Translate Bio, Inc.

    Translate Bio is a leading mRNA therapeutics company developing a new class of pot...

    Translate Bio is a leading mRNA therapeutics co...

    Filing Type:    PU
    Advaxis, Inc.

    Advaxis, Inc.

    Advaxis was founded on the vision that no one should suffer from the burdens of ca...

    Advaxis was founded on the vision that no one s...

    Filing Type:    PU
    Gilead Sciences, Inc.

    Gilead Sciences, Inc.

    Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers...

    Gilead Sciences, Inc. is a research-based bioph...

    Filing Type:    PU
    20/20 GeneSystems, Inc.

    20/20 GeneSystems, Inc.

    20/20 GeneSystems, Inc. an early stage digital diagnostics company with the core m...

    20/20 GeneSystems, Inc. an early stage digital ...

    Fundraising Status:    SASBEC
    Filing Type:    RA
    ProLung, Inc.

    ProLung, Inc.

    ProLung is a medical technology company specializing in innovative predictive anal...

    ProLung is a medical technology company special...

    Filing Type:    PU
    Harpoon Therapeutics, Inc.

    Harpoon Therapeutics, Inc.

    Harpoon Therapeutics is a clinical-stage immunotherapy company developing a novel ...

    Harpoon Therapeutics is a clinical-stage immuno...

    Filing Type:    PU
    Replimune Group, Inc.

    Replimune Group, Inc.

    Cancer is one of the most difficult diseases to treat. It is constantly changing, ...

    Cancer is one of the most difficult diseases to...

    Filing Type:    PU
    PDS Biotechnology Corporation

    PDS Biotechnology Corporation

    PDS Biotechnology has a growing pipeline of clinical-stage immunotherapies to trea...

    PDS Biotechnology has a growing pipeline of cli...

    Filing Type:    PU
    Regeneron Pharmaceuticals, Inc.

    Regeneron Pharmaceuticals, Inc.

    We are a leading science and technology company that delivers life-transforming me...

    We are a leading science and technology company...

    Filing Type:    PU
    AcelRx Pharmaceuticals, Inc.

    AcelRx Pharmaceuticals, Inc.

    AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the ...

    AcelRx Pharmaceuticals, Inc. is a specialty pha...

    Filing Type:    PU
    Medivie USA Inc

    Medivie USA Inc

    Medivie Therapeutic is an Israeli public company, which developed Laboraide – a ...

    Medivie Therapeutic is an Israeli public compan...

    Filing Type:    RA
    ©2026 National Investor Network. All Rights Reserved.